1. Hypertension

   • Artur Beltrame Ribeiro
   • Osvaldo Kohlmann Jr
   • Oswaldo Luiz Ramos

   Section 1 27 October 2012 Pages: 1 - 5

2. Antihypertensive Drugs Interacting with α- and β-Adrenoceptors

   • P. A. van Zwieten

   Section 1 27 October 2012 Pages: 6 - 19

3. Experimental Studies on the Neurocardiovascular Effects of Urapidil

   • Richard A. Gillis
   • Kenneth J. Kellar
   • Kenneth Dretchen

   Section 1 27 October 2012 Pages: 20 - 33

4. Human Pharmacology of Urapidil

   • Alexander M. M. Shepherd

   Section 1 27 October 2012 Pages: 34 - 39

5. Drug Treatment of Hypertension

   • B. N. C. Prichard

   Section 2 27 October 2012 Pages: 40 - 52

6. Effects of α-Adrenoceptor Blockers on Renal Function and Blood Pressure Adjustment in Human Hypertension

   • Gastone Leonetti

   Section 2 27 October 2012 Pages: 53 - 59

7. Systemic and Regional Haemodynamic Profile of Diuretics and α- and β-Blockers

   • Albert Mimran
   • Guilhem Ducailar

   Section 2 27 October 2012 Pages: 60 - 69

8. Haemodynamic Effects of Urapidil in Arterial Hypertension and Congestive Heart Failure

   • Franz H. Messerli

   Section 2 27 October 2012 Pages: 70 - 73

9. Renal Haemodynamic and Neurohumoral Responses to Urapidil in Hypertensive Man

   • P. W. de Leeuw
   • P. N. van Es
   • W. H. Birkenhäger

   Section 2 27 October 2012 Pages: 74 - 77

10. The Development and Progression of Chronic Renal Disease

    • Robert G. Narins

    Section 3 27 October 2012 Pages: 78 - 82

11. Effects of Different Antihypertensive Drugs on Left Ventricular Function

    • Raúl Oliveri

    Section 3 27 October 2012 Pages: 83 - 89

12. Comparison between the Effects of Urapidil and Methyldopa on Left Ventricular Hypertrophy and Haemodynamics in Humans

    • Carlos A. Feldstein
    • Antonio O. Olivieri
    • Rubén Porto Sabarís

    Section 3 27 October 2012 Pages: 90 - 97

13. Mechanisms of Complete Baroreceptor Resetting in Hypertension

    • Eduardo Moacyr Krieger

    Section 4 27 October 2012 Pages: 98 - 103

14. Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension

    • G. Grassi
    • G. Parati
    • G. Mancia

    Section 4 27 October 2012 Pages: 104 - 110

15. Systemic Arterial Hypertension and Coronary Atherosclerosis

    • Gustavo Sánchez Torres
    • Carlos Posadas Romero
    • Ismael Hernández Santamaría

    Section 4 27 October 2012 Pages: 111 - 117

16. Serum Lipoproteins During Treatment with Antihypertensive Drugs

    • Peter Weidmann
    • Claudia Ferrier
    • Bernhard N. Trost

    Section 4 27 October 2012 Pages: 118 - 134

17. Hypertension and Diabetes

    • Maria Teresa Zanella
    • Regina C. M. Santiago
    • Artur B. Ribeiro

    Section 4 27 October 2012 Pages: 135 - 141

18. Responders and Non-Responders to Antihypertensive Treatment

    • C. J. Bulpitt

    Section 5 27 October 2012 Pages: 142 - 146

19. Efficacy of Urapidil in the Management of Essential Hypertension

    • J. Rosenthal
    • R. Haerlin
    • W. Wurst

    Section 5 27 October 2012 Pages: 147 - 155

20. Double-Blind Comparison of Urapidil and Prazosin in the Treatment of Patients with Essential Hypertension

    • Yoshihiro Kaneko
    • the Urapidil Study Group in Japan

    Section 5 27 October 2012 Pages: 156 - 163

21. Comparison of Urapidil and Atenolol in Hypertension

    • Esther Török
    • Maria Wagner
    • Marta Podmaniczky

    Section 5 27 October 2012 Pages: 164 - 172

22. Efficacy of Once-Daily Urapidil Treatment in Mild or Moderate Essential Hypertension Assessed by Ambulatory 24-Hour Blood Pressure Monitoring

    • Bruno Trimarcö
    • G. Rosiello
    • M. Volpe

    Section 5 27 October 2012 Pages: 173 - 181

23. Guidelines for the Treatment of Mild Hypertension

    • W. H. Birkenhäger
    • P. W. de Leeuw

    Section 6 27 October 2012 Pages: 182 - 187

24. Urapidil in the Treatment of Hypertension

    • Clive Rosendorff

    Section 6 27 October 2012 Pages: 188 - 192